COAGADEX

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Lithuania, Poland, UK.

Active ingredients

The drug COAGADEX contains one active pharmaceutical ingredient (API):

1	Coagulation factor X UNII 0P94UQE6SY - COAGULATION FACTOR X HUMAN
	Coagulation factor X is derived from human plasma and used as a replacement for the naturally existing coagulation factor X in patients with hereditary factor X deficiency.
	Read more about Coagulation factor X

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COAGADEX Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD13		B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1713776, 1713787
GB	Medicines & Healthcare Products Regulatory Agency	327525, 360753
LT	Valstybinė vaistų kontrolės tarnyba	1079856, 1079857
PL	Rejestru Produktów Leczniczych	100367737, 100367743